Navigation Links
Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
Date:2/23/2012

ROCKVILLE, Md., Feb. 23, 2012 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that it will participate in three upcoming investor conferences.

On Tuesday, February 28, 2012, Mihael Polymeropoulos, M.D., Vanda's President and CEO, will participate in a Neurology-focused discussion at RBC Capital Markets' Global Healthcare Conference in New York City.

On Wednesday, February 29, 2012, Dr. Polymeropoulos will deliver a corporate presentation at Citi's 2012 Global Health Care Conference at 2:00 pm Eastern Time in New York City. 

The Citi conference presentation will be available live on Vanda's corporate website, where it will be archived for 30 days.  To access this presentation, log on to http://www.vandapharma.com and click on the "Presentations" option in the Investor Relations section.  Please connect to the website several minutes prior to the start of the live presentation.

On Monday, March 5, 2012, Dr. Polymeropoulos will deliver a corporate presentation at Cowen and Company's 32nd Annual Health Care Conference in Boston.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.  For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.

Company Contact:
Cristina Murphy
Senior Communications Manager
Vanda Pharmaceuticals Inc.
(240) 599-4500
cristina.murphy@vandapharma.com

 


'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter 2011 and Full Year 2011 Results
2. Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel
3. Vanda Pharmaceuticals Reports Third Quarter 2011 Results
4. Vanda Pharmaceuticals Appoints Chief Commercial Officer
5. Vanda Pharmaceuticals to Participate in UBS Global Life Sciences Conference
6. Vanda Pharmaceuticals to Participate in Stifel Nicolaus Global Healthcare Conference and Jefferies Fall 2011 Mid-Atlantic Corporate Access Day
7. Vanda Pharmaceuticals Reports Second Quarter 2011 Results
8. Vanda Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Probiomed S.A. de C.V. for Commercialization of Fanapt™ in Mexico
10. Vanda Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
11. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 KEY FINDINGS ... Patient warming and cooling ... during surgeries, lowering the risks of neurological disorders post cardiac ... The patient warming systems can be segmented into convective warming ... turn reduce the stay at hospitals thus, lowering the healthcare ...
(Date:12/8/2016)... KEY FINDINGS The global medical ... Various reasons for growth of the medical lifting sling ... chronic diseases, high recovery cost of injuries and government ... lifting sling refers to an assistive device that helps ... connect to the lift and hold the patient. It ...
(Date:12/8/2016)... Allergy Diagnostics Market: Scope and Methodology ... are used to determine the presence of allergens ... etc. in the samples by determining the presence ... report on global allergy diagnostics market, analyzes the ... report consists of an executive summary that provides ...
Breaking Medicine Technology:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... Mediaplanet today ... for organ transplantation while encouraging readers to sign up as an organ donor for ... organ transplant. , An organ donor can save up to 8 saves through ...
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... ... education program through the Pennsylvania Cable Network (PCN) during the summer of 2016. ... Injury Implementation Grant provided by the United States Department of Health and Human ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ DiGilio ... the first national #QuackGivesBack campaign which supported local breast cancer organizations during National ... Quack Gives Back initiative, and we’re very pleased with the participation ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... for customers and employees that are both engaging and easy to use. Coming ... Technology, the software company revealed today its plans to roll out new AI-powered ...
Breaking Medicine News(10 mins):